Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment.

Osilla KC, Ryan G, Bhatti L, Goetz M, Witt M, Wagner G.

AIDS Patient Care STDS. 2009 Dec;23(12):993-9. doi: 10.1089/apc.2009.0153.


Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.

Osilla KC, Wagner G, Garnett J, Ghosh-Dastidar B, Witt M, Bhatti L, Goetz MB.

AIDS Patient Care STDS. 2011 Sep;25(9):533-8. doi: 10.1089/apc.2011.0048. Epub 2011 Aug 8.


Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection.

Wagner G, Ryan G, Osilla KC, Bhatti L, Goetz M, Witt M.

AIDS Patient Care STDS. 2009 Sep;23(9):715-25. doi: 10.1089/apc.2009.0049.


Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers.

Butt AA, Khan UA, Shaikh OS, McMahon D, Dorey-Stein Z, Tsevat J, Lo Re V 3rd.

HIV Clin Trials. 2009 Jan-Feb;10(1):25-32. doi: 10.1310/hct1001-025.


Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.

Winnock M, Bani-Sadr F, Pambrun E, Loko MA, Carrieri P, Neau D, Morlat P, Marchou B, Dabis F, Salmon D; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO13 HEPAVIH Study Group.

HIV Med. 2013 Aug;14(7):430-6. doi: 10.1111/hiv.12023. Epub 2013 Mar 5.


Hepatitis C treatment experiences and decision making among patients living with HIV infection.

Bova C, Ogawa LF, Sullivan-Bolyai S.

J Assoc Nurses AIDS Care. 2010 Jan-Feb;21(1):63-74. doi: 10.1016/j.jana.2009.07.009. Epub 2009 Oct 22.


Challenges facing providers caring for HIV/HCV-coinfected patients.

Lekas HM, Siegel K, Leider J.

Qual Health Res. 2012 Jan;22(1):54-66. doi: 10.1177/1049732311418248. Epub 2011 Aug 8.


Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa.

Martin NK, Devine A, Eaton JW, Miners A, Hallett TB, Foster GR, Dore GJ, Easterbrook PJ, Legood R, Vickerman P.

AIDS. 2014 Jan;28 Suppl 1:S35-46. doi: 10.1097/QAD.0000000000000084.


Provider and patient correlates of provider decisions to recommend HCV treatment to HIV co-infected patients.

Wagner G, Osilla KC, Garnett J, Ghosh-Dastidar B, Bhatti L, Witt M, Goetz MB.

J Int Assoc Physicians AIDS Care (Chic). 2012 Jul-Aug;11(4):245-51. doi: 10.1177/1545109712444163. Epub 2012 May 7.


Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.

Roux P, Fugon L, Winnock M, Salmon-Céron D, Lacombe K, Sogni P, Spire B, Dabis F, Carrieri MP; ANRS-CO-13-HEPAVIH Study Group.

Addiction. 2012 Jan;107(1):152-9. doi: 10.1111/j.1360-0443.2011.03608.x. Epub 2011 Oct 12.


Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of direct-acting antiviral-based therapy.

Taylor LE, Swan T, Matthews GV.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S118-24. doi: 10.1093/cid/cit326. Review.


Hepatitis C Virus in the HIV-infected patient.

Andersson K, Chung RT.

Clin Liver Dis. 2006 May;10(2):303-20, viii. Review.


Treatment of hepatitis C virus in the coinfected patient.

Brennan C.

J Assoc Nurses AIDS Care. 2003 Sep-Oct;14(5 Suppl):52S-79S. Review.


Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.

Sherman KE, Rouster SD, Stanford S, Blackard JT, Shire N, Koziel M, Peters M, Chung RT; AIDS Clinical Trials Group 5071 Study Team.

J Infect Dis. 2010 Mar;201(5):712-9. doi: 10.1086/650490.


Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients.

Braun DL, Rauch A, Durisch N, Eberhard N, Anagnostopoulos A, Ledergerber B, Metzner KJ, Böni J, Weber R, Fehr J.

HIV Med. 2014 Nov;15(10):625-30. doi: 10.1111/hiv.12166. Epub 2014 Jun 4.


Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV.

Weiss JJ, Gorman JM.

Curr HIV/AIDS Rep. 2006 Nov;3(4):176-81. Review.


HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults.

Ogawa LM, Bova C.

Subst Use Misuse. 2009;44(7):915-33. doi: 10.1080/10826080802486897.

Items per page

Supplemental Content

Write to the Help Desk